In addition, it has been shown that PCAs reduce blood glucose levels in a dose-dependent manner favoring the expression and externalization of GLUT4 on the cell surface and improve insulin resistance by directly activating IR and other targets of the insulin signaling pathway [97,127]. This evidence concerns the gene INS and Insulin resistance.